Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001557746-14-000001
Filing Date
2014-10-08
Accepted
2014-10-08 11:22:58
Documents
1
Effectiveness Date
2014-10-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11613
  Complete submission text file 0001557746-14-000001.txt   12653
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-226021 | Film No.: 141147255